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httpUsing distal revascularization with interval ligation
as the primary treatment of hand ischemia after
dialysis access creation
Rahim Aimaq, MD,a and Steven G. Katz, MD,b Pasadena and Los Angeles, Calif
Background: Arterial steal syndrome after angioaccess surgery can lead to potentially devastating complications. Past
treatments either ensured loss of the newly created access through ligation or attempted salvage by increasing resistance
within the ﬁstula. None of these proved to be entirely satisfactory. In 1994, we began to employ distal revascularization
with interval ligation (DRIL) as our primary method of relieving hand ischemia after dialysis access creation. Described
here is our experience with this procedure.
Methods: After institutional review board approval, the charts of patients undergoing the DRIL procedure for relief of
hand ischemia after dialysis access surgery were reviewed. Patient demographics, risk factors, types of ﬁstulas, and
indications for operation were recorded. The clinical results of DRIL surgery, as well as ﬁstula and bypass graft patency,
were noted.
Results: Between May 1994 and August 2011, 81 DRIL procedures were performed on 77 patients ranging from 37 to 94
(mean, 65) years of age. Forty-four were female and 33 were male, with diabetes present in 83.3%. DRIL procedures were
performed for ischemic symptoms after 37 autogenous brachiocephalic, 30 prosthetic bridge, and 14 autogenous bra-
chiobasilic ﬁstulas. Thirty-eight DRIL procedures were performed for ischemic rest pain (46.9%), 21 for digital ulceration
(25.9%), 16 for neurological deﬁcits (19.7%), and six for digital gangrene (7.4%). Complete symptom resolution was seen
in 31 patients with ischemic rest pain (81.6%), 19 patients with digital ulcerations (90.5%), nine patients with neuro-
logical deﬁcits (56.3%), and ﬁve patients with digital gangrene (83.3%). Fistula and brachial-brachial bypass survival 60
months after the DRIL procedure was 56% and 96.9%, respectively. The overall complication rate was 17.2%, and no
patients died within 30 days of operation.
Conclusions: The DRIL procedure is a very effective treatment for symptomatic steal syndrome and is associated with low
morbidity and mortality. It is extremely effective in the treatment of ischemic hand pain and tissue loss, but less so for
neurological sequelae. It can allow for prolonged ﬁstula utilization. (J Vasc Surg 2013;57:1073-8.)As the number of patients requiring hemodialysis
continues to grow, complications relating to vascular ac-
cess become more frequent. Although uncommon, hand
ischemia resulting from an arterial steal syndrome can be
severely debilitating and can be seen in up to 5% of patients
with upper extremity arteriovenous ﬁstulas.1 Symptoms
may include ischemic rest pain, development of neurolog-
ical deﬁcits, digital ulceration, and ﬁnger gangrene.
For many years, ﬁstula ligation remained the treatment
of choice for symptomatic arterial steal. However, this
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of dialysis. A number of procedures including anastomotic
banding, small segment graft interposition, and inﬂow
relocation both proximally and distally have been attemp-
ted to abolish steal symptoms and maintain graft patency.
These have met with varying degrees of success.
In 1988, Schanzer and his colleagues developed
a unique approach to the treatment of hand ischemia
resulting from dialysis ﬁstula creation.1 This physiological
approach, which combined arterial ligation to alleviate
reversal of ﬂow in the affected artery with the creation of
a bypass distal to the area of ﬂow interruption, was later
termed the distal revascularization with interval ligation
(DRIL) procedure. In 1994, we adopted this procedure
as our preferred method for treating symptomatic steal
syndrome.2 This article summarizes our 18-year experience
in using the DRIL procedure to treat hand ischemia after
dialysis access creation.
METHODS
After institutional review board approval, the charts of
all patients who had undergone the DRIL procedure for
relief of hand ischemia after dialysis access creation were
reviewed. Patients undergoing ﬁstula ligation or proce-
dures other than DRIL during the course of the study
were excluded from statistical analysis. Two surgeons1073
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procedures. Patient demographics and comorbidities were
noted. Type of ﬁstula (autogenous brachiocephalic, upper
arm basilic transposition, or prosthetic graft) and type of
conduit employed for brachial-brachial bypass were
recorded.
Indications for intervention were divided into four
categories: development of ischemic rest pain, digital
ulceration, extremity gangrene, and new neurological
deﬁcit. Patients with mild sensory deﬁcits or dysesthesias
were not considered candidates for revascularization. The
DRIL procedure was said to have been successful in treat-
ing rest pain if all symptoms were relieved; in treating
digital ulceration if total healing was accomplished; in treat-
ing gangrene if healing of a local amputation was achieved;
and in treating a neurological deﬁcit if it was completely
resolved. Survival for a ﬁstula was deﬁned as the duration
of its use prior to its abandonment as the primary method
of achieving dialysis access, and primary patency for a bypass
graft was determined by clinical examination or duplex
scan. Fistula abandonment within 6 months of a DRIL
procedure was considered to be an early loss; all other
losses were considered late. Patients selected for a DRIL
procedure had at least one of the following in addition to
the obvious clinical signs of hand ischemia: presence of
diminished Doppler wave forms in the radial and ulnar
arteries that augmented with manual ﬁstula compression;
reversal of ﬂow in the brachial artery; increase in peak
velocities seen in the radial and ulnar arteries with ﬁstula
compression; or increase in distal arterial ﬂow with ﬁstula
compression seen on angiography. Adequacy of arterial
inﬂow was documented before the DRIL procedure by
arterial duplex scan or contrast angiography. A stenosis
greater than 50% was considered to be hemodynamically
signiﬁcant. The operative technique has previously been
described in detail.1-3 Routine noninvasive ﬁstula graft
surveillance was not performed.
Demographic and comorbidity data were recorded per
patient, and patency data were calculated for each indi-
vidual procedure. Follow-up was determined by review of
ofﬁce and inpatient admission charts and a radiology
database. Physical exam and noninvasive vascular imaging
determined patency. Kaplan-Meier life tables were created,
and differences between groups tested by the log rank
method. A two-tailed Fisher exact test was used to compare
categorical factors. Statistical signiﬁcance was assumed at
a P value <.05. All statistical calculations were performed
using PASW 18.0 software (formerly SPSS, Chicago, Ill).
RESULTS
Between May 1994 and August 2011, 81 DRIL proce-
dures were performed on 77 patients with symptomatic
steal syndrome. Forty-four patients were female (57%)
and 33 were male (43%). Their ages ranged from 37 to
94 years (mean, 65 years). Hypertension was present in
95.5% of patients, and diabetes in 83.3%; 62.1% had co-
existent peripheral vascular disease. This is in contrast to
our overall dialysis access population in which 62.1% aremale and 37.9% are diabetic (P ¼ .012 and P < .001,
respectively). Twenty-one patients had preoperative arch
and extremity angiography, with one inﬂow lesion discov-
ered and corrected with angioplasty.
During the study period other treatment modalities for
angioaccess-related ischemic steal included nine primary
ﬁstula ligations, two banding procedures, and one revision
using distal inﬂow (RUDI). Primary ligation was per-
formed in ﬁve patients whose ﬁstulas were deemed unsal-
vageable because of poor function, repetitive thrombosis,
aneurysmal degeneration, uncorrectable inﬂow disease, or
severe distal disease and in four patients who no longer
required hemodialysis. The steal syndrome was eliminated
in all nine patients. The banding and RUDI procedures
failed to resolve the ischemic symptoms. The RUDI
patient and one of the banding patients had ﬁstula ligation;
the second banding patient underwent a successful DRIL
procedure.
Thirty-eight DRIL procedures were performed for
ischemic rest pain (46.9%), 21 for digital ulceration
(25.9%), 16 for neurological deﬁcits (19.7%), and six for
digital gangrene (7.4%). The median time to diagnosis of
steal symptoms after access creation was 6 days for neuro-
logical deﬁcits, 54.5 days for ischemic rest pain, 193 days
for digital gangrene, and 370 days for digital ulceration.
Thirty-seven DRIL procedures were performed after
creation of a brachiocephalic ﬁstlula, 30 after creation of
a prosthetic bridge ﬁstula and 14 after creation of a brachio-
basilic ﬁstula. This represents 3.5% of our dialysis patients
undergoing creation of brachiobasilic ﬁstulas, 3.1% of
patients undergoing creation of brachiocephalic ﬁstulas,
and 1.35% of patients undergoing creation of prosthetic
bridge ﬁstulas. Five prosthetic bridge ﬁstulas were placed
in the forearm; the remaining ﬁsulas were placed in the
upper arm.Median time to develop steal symptomswas 53.5
days for those with prosthetic bridge ﬁstulas, 64 days for
those with brachiobasilic ﬁstulas, and 193 days for those
with brachiocephalic ﬁstulas. In those individuals who devel-
oped steal syndrome, 60% of patients with prosthetic bridge
ﬁstulas and 48.6% of patients with brachiocephalic ﬁstulas
presented with ischemic rest pain, whereas 57.1% of those
with brachiobasilic ﬁstulas presented with neurological
deﬁcits (Table).
After the DRIL procedure, complete symptom reso-
lution was seen in 31 patients with ischemic rest pain
(81.6%), 19 patients with digital ulcerations (90.5%),
nine patients with neurological deﬁcits (56.3%), and ﬁve
patients with digital gangrene (83.3%). Of the seven
patients with incomplete resolution of rest pain after the
DRIL procedure, four underwent ﬁstula ligation and
three felt the severity of their pain did not warrant further
treatment. Among those undergoing ligation, symptoms
resolved completely in three. The two patients whose
digital ulcerations failed to heal after DRIL underwent
successful local amputations. Of the seven patients whose
neurological deﬁcits persisted after DRIL, four under-
went ﬁstula ligation and three declined further interven-
tion. After ﬁstula ligation one patient made a complete
Months 0 12 24 36 48 60 
Number at risk 81 44 32 25 21 15 
Standard error  (%) 0 4.8 6.1 6.7 7 7 
Cum. patency  (%) 100 80 68 60.9 56 56 
Fig 1. Overall ﬁstula survival after the distal revascularization with
interval ligation (DRIL) procedure.
Table. Distribution of ischemic steal symptoms by type of ﬁstula
Type of arteriovenous ﬁstula Rest pain Neurological deﬁcits Digital ulcer Digital gangrene Total
Brachiocephalic 18 (48.6%) 2 (5.4%) 13 (35.1%) 4 (10.8%) 37 (100%)
Brachiobasilic 2 (14.3%) 8 (57.1%) 3 (21.4%) 1 (7.1%) 14 (100%)
Prosthetic bridge 18 (60.0%) 6 (20%) 5 (16.7%) 1 (3.3%) 30 (100%)
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neurological deﬁcits. The single patient with digital
gangrene who failed to heal from a local amputation after
DRIL was found to have an occluded brachial bypass
graft. He underwent ﬁstula ligation with resolution of
his ischemic symptoms.
Overall ﬁstula survival 12, 36, and 60 months after the
DRIL procedure was 80, 60.9, and 56%, respectively
(Fig 1). Fistula patency at 12, 36, and 60 months was
85.1, 67.1, and 67.1% for autogenous ﬁstulas and 71.9,
51.1, and 39.7% for prosthetic ﬁstulas. Autogenous ﬁstulas
had a signiﬁcantly longer survival than prosthetic bridge
ﬁstulas (P ¼ .028). Early ﬁstula loss was due to ligation
in eight patients, thrombosis in six, excision for infection
in three, and lack of maturation in one brachiocephalic
ﬁstula. Late ﬁstula failure was due to repetitive thrombosis
in nine, ligation in three, and excision for infection in one.
Fistulas were ligated for persistent symptoms after DRIL in
nine patients, bleeding in one patient, and symptoms of
hand ischemia that developed in a single patient 2 years
after an initially successful DRIL. All ﬁstulas excised for
infection were prosthetic.
Patency of the brachial-brachial bypass grafts was 96.9%
at 60 months (Fig 2). Bypass graft conduits included 74
saphenous veins, 3 basilic veins, 3 cephalic veins, and 1 poly-
tetraﬂuoroethylene graft. Bypass graft failure occurred in
one saphenous vein graft, in one basilic vein graft, and in
the lone prosthetic conduit. The saphenous vein and pros-
thetic graft occlusions resulted in the development of
ischemic rest pain. A repeat bypass with saphenous vein
was performed in both cases with resolution of the symp-
toms. The basilic vein failure was noted on duplex scan
when a patient with digital gangrene was unable to heal
from a local amputation. Fistula ligation was performed
with prompt amputation healing. All bypass graft occlusions
occurred within 4 months of the initial DRIL procedure.
The overall complication rate was 17.2%. There were
11 saphenous vein harvest site complications. Four patients
had abscess formation requiring operative drainage, and
three had wound infections requiring antibiotic administra-
tion. Three patients developed groin wound hematomas,
one of which required surgical evacuation, and one patient
formed a seroma requiring multiple percutaneous aspira-
tions. An additional three patients developed cellulitis in
the brachial bypass incision. All were successfully treated
with antibiotics alone. No patient experienced postopera-
tive pneumonia or myocardial infarction in our series.
There were no deaths within 30 days of operation.DISCUSSION
It has been estimated that there are more than 800,000
patients in the United States with end-stage renal disease.4
Although these patients constitute less than 1% of the
Medicare population, expenditure for their care accounts
for 7% of Medicare spending.5 A signiﬁcant portion of these
costs are associated with chronic hemodialysis.6 With the
rate of end-stage renal disease growing by an estimated
15% per year, the demand for dialysis ﬁstulas will surely
increase and a signiﬁcant emphasis will be placed on
successful outcomes after angioaccess surgery.7 Ischemic
steal complicating ﬁstula creation can lead to increased
cost and be a signiﬁcant cause of patient morbidity.
The overall incidence of steal syndrome in our series
was 2.9%, which is similar to that reported by others.8,9
Patients who developed ischemic symptoms were more
likely to be female and to have diabetes. The onset of
symptoms was earliest for those presenting with an acute
neurological deﬁcit, and this complication was seen almost
Months 0 12 24 36 48 60
Number at risk 81 45 35 30 25 21
Standard error (%) 0 2.1 2.1 2.1 2.1 2.1
Cum. patency  (%) 100 96.9 96.9 96.9 96.9 96.9
Fig 2. Overall brachial-brachial bypass survival after the distal
revascularization with interval ligation (DRIL) procedure. Stan-
dard error does not exceed 10%.
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ﬁstulas. The ischemic symptoms seen after brachiocephalic
ﬁstula creation were for the most part limited to rest pain
and tissue loss, which occurred at a much later date than
ischemic complications after other ﬁstula types. In our
experience, steal phenomenon after brachiocephalic access
creation developed predominantly after ﬁstula maturation
and late vein dilatation.
The worth of the DRIL procedure should be based on
how well it accomplishes its goal of abolishing ischemic
symptoms while preserving access patency. Previous reports
suggest that the DRIL procedure is more successful then
banding procedures and at least as efﬁcacious as relocation
of arterial inﬂow in abolishing the symptoms of the steal
syndrome.10 In this study, the DRIL procedure was ex-
tremely successful in treating ischemic rest pain, digital
ulceration, and ﬁnger gangrene, completely relieving symp-
toms in more than 80% of patients. All patients with the
aforementioned symptoms not effectively treated by the
DRIL procedure had resolution of their ischemia after
ﬁstula ligation, local amputation, or repeat brachial bypass.
In no patient did the antecedent DRIL preclude recovery
from the access-related steal. The DRIL procedure was
not as successful in treating those patients presenting
with neurological deﬁcits, especially those occurring within
7 days of ﬁstula placement. Four of the seven patients with
neurological deﬁcits not responding to the DRIL proce-
dure presented within 24 hours of access creation with
severe sensory and motor deﬁcits out of proportion tothe degree of ischemia observed. A number of the patients
developing these changes almost certainly had ischemic
monomelic neuropathy, and this might explain the inability
of the DRIL procedure to eliminate their symptom-
atology.11 Patients with ischemic monomelic neuropathy
often fail to present with other signs of profound ischemia,
but some will beneﬁt from immediate revascularization.
In light of this we do not recommend additional time-
consuming testing such as evoked potentials and nerve
conduction velocities in those with severe deﬁcits, but
suggest proceeding immediately with DRIL or ﬁstula liga-
tion. It is important to note that of those patients under-
going ﬁstula ligation for persistent neurological deﬁcits
after failure of the DRIL procedure, only 25% regained
full function of their affected extremity. Although one
cannot discount the delay in treatment caused by the ante-
cedent attempt at ﬁstula preservation prior to ligation, it is
unclear whether initial ligation would have been more
beneﬁcial in treating this condition.
To be truly efﬁcacious, in addition to alleviating symp-
toms, the DRIL procedure must maintain access function.
In our series, the long-term ﬁstula survival of 56% at 5 years
would appear to validate the merits of this procedure.
Although the durability of autogenous ﬁstulas after the
DRIL procedure is superior to that of prosthetic grafts,
we believe that the length of ﬁstula survival is sufﬁcient
to justify the use of this procedure even in those with non-
autogenous accesses. Of note, one-third of the ﬁstulas that
were eventually lost were intentionally ligated for failure of
the DRIL procedure to relieve symptoms or removed
because of infection and did not fail as a result of repetitive
thrombosis or inability to sustain adequate patient dialysis.
Our data would suggest that the DRIL procedure does not
appear to adversely affect long-term survival of the hemo-
dialysis access in the involved extremity.12,13
Some have been reluctant to perform the DRIL
procedure, fearing that brachial artery ligation might
eventually compromise extremity perfusion and result in
signiﬁcant disability or limb loss. Several authors have
advocated performance of the brachial bypass alone or the
use of an alternative procedure such as proximalization
of arterial inﬂow or the use of a more distal inﬂow source
(RUDI).14-16 Each of these alternate procedures has its
disadvantages. Failure to perform the interval ligation may
compromise procedural success. The proximalization of
arterial inﬂow procedure would appear to be at least as tech-
nically demanding as the DRIL procedure and relies on
a prosthetic conduit for inﬂow, perhaps compromising
ultimate ﬁstula survival. Although midterm results appear
satisfactory, its use has not been widely studied and its
long-term outcomes have not been validated. Experience
in creation of primary dialysis access suggests that the use
of distal inﬂow based on the radial or ulnar arteries may
compromise maturation and long-term access survival in
women and diabetics, two of the groups most likely to
develop steal.17,18 We believe the reluctance in ligating an
axial artery in the upper extremity is not justiﬁed. In our
experience, brachial-brachial bypass graft patency has been
JOURNAL OF VASCULAR SURGERY
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conduit. In the rare instance of graft occlusion, limb salvage
was achieved in all instances by performing a repeat bypass
procedure or ﬁstula ligation. In no case was acute, irrevers-
ible ischemia precipitated by bypass graft thrombosis, even
in the face of antecedent brachial artery ligation. To avoid
compromising future angioaccess, we are reluctant to use
upper extremity veins as the brachial-brachial bypass
conduit. In those lacking suitable saphenous vein, we
believe other treatment modalities to address ischemic steal
should be explored.
All complications requiring operative intervention were
related to the saphenous vein harvest site. The use of pre-
procedural vein mapping or endoscopic vein harvest might
help to reduce problems related to ﬂap formation and the
resultant skin and fat necrosis.19,20 Several years ago, our
institution substituted chlorhexidine for povidine-iodine
skin preparation in the operating room, and this led to
a decrease in all our infectious groin wound complications,
including those in patients undergoing DRIL.21 Hema-
toma formation may be diminished by heparin reversal
with protamine at the conclusion of the procedure and
the use of desmopressin acetate to correct platelet function
in these patients, who are all on chronic hemodialysis.22 In
this series, it is important to note that no signiﬁcant
medical complications such as pneumonia and myocardial
infarction occurred in the perioperative period, and no
deaths occurred within 30 days of operation.
This study illustrates several important points. The
success of the DRIL procedure in alleviating symptoms
of ischemic steal in this series is similar to that described
by others.9,10 The primary patency of the DRIL bypass
was outstanding, and even in the face of bypass graft occlu-
sion, limb loss did not occur. Our data would suggest that
one should not abandon the use of this procedure fearing
the consequences of brachial artery ligation. Perhaps the
most important ﬁnding in this series is the prolonged access
survival that can be achieved after the DRIL procedure.
We acknowledge that the limitation of this study is that
it represents a single center’s experience, but believe
a randomized trial is unlikely in this population.
CONCLUSIONS
The DRIL procedure is effective in alleviating the
symptoms of ischemic steal after dialysis ﬁstula creation
while preserving access function. It can be recommended
as the primary treatment for those patients with ischemic
rest pain, digital ulcerations, or ﬁnger gangrene with an
anticipated high degree of success. Even if it proves to
be unsuccessful, treatment with alternative techniques will
lead to eventual resolution of symptomatology. It performs
less well in those presenting with acute neurological def-
icits. In about half of the patients, it may be successful
in resolving the deﬁcits while preserving access patency.
When unsuccessful, permanent neurological sequelae are
frequent, and it is unclear if initial treatment with the
DRIL and the resultant delay in treatment with ligation
may compromise ultimate patient outcomes.AUTHOR CONTRIBUTIONS
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this paper that reviews the experience in Pasadena with distal revas-
cularization-interval ligation (DRIL) for the treatment of vascular
access-induced ischemia. The clinical results the authors achieved
are similar to that published elsewhere including our own extensive
experience with this procedure in Tucson. The risk factors identi-
ﬁed by the authors similarly correlate with previous studies. Inter-
estingly, the authors reported diabetes in only 83% of the patients
with signiﬁcant steal. In my own experience with more than 100
DRIL procedures, I have seen clinically signiﬁcant steal in only
two patients without diabetes. Similar to other reports on the
DRIL procedure, the authors demonstrated that the outcomes
of relieving ischemia while preserving access were achieved with
acceptable durability. The physiology of clinically signiﬁcant steal
remains complex. I have a number of questions for the authors:
1. Given their experience, what do the authors recommend pre-
emptively to minimize this problem? What is the minimum
workup before access construction that the authors perform
and how does that impact their algorithm for access selection?
2. How do the authors assess their patients intraoperatively at the
time of access creation to determine if ischemia is going to be
a problem postoperatively? How do the authors handle an
ischemic hand at the conclusion of access construction?
3. Prior to proceeding with treatment for access-induced
ischemia, what workup do the authors perform on the patient?
How does the access ﬂow impact the decision to do a DRIL
versus a banding, RUDI, proximalization of arterial inﬂow,
or ligation? Gary Gelbﬁsh, a prominent access surgeon from
Brooklyn, stratiﬁes the treatment algorithm for ischemia on
the basis of the ﬂow rate through the access. Do the authors
have any thoughts in this regard?
4. Do the authors have any recommendations for patients with
isolated early neurological deﬁcits? How do the authors distin-
guish ischemic monomelic neuropathy, steal, and simple neu-
ropraxia related to the trauma adjacent to the nerves fromthe access placement? These are particularly challenging
patients as many of them have only physiological steal whose
symptoms will resolve over time.
5. For high-ﬂow ﬁstulas I have started using ﬂow-based banding
to treat ischemic steal. This technology allows for the intrao-
perative measurement of both direction and quantity of ﬂow
with the end points of banding evolving into maintaining
adequate volume ﬂow through the access while restoring ante-
grade ﬂow in the brachial artery distal to the access. Given their
experience, do the authors have any thoughts on this
technique?
I thank the program committee for allowing me the privilege
of discussing this paper.
Dr Steven G. Katz. Dr Berman, thank you for your insightful
remarks and thoughtful questions, which I will attempt to answer
in order. Before access creation we routinely obtain vein mapping
and liberally employ duplex scanning of the upper extremity donor
arteries if there is any question of an inﬂow problem. While in the
operating room, we check for Doppler signals in the radial and
ulnar arteries and, if absent, consider immediate performance of
a DRIL procedure. Prior to performance of a DRIL procedure,
we routinely perform noninvasive testing to look for reversal of
ﬂow in the brachial artery and to demonstrate ﬂow augmentation
with ﬁstula compression. In addition, we perform a ﬁstulogram to
evaluate arterial inﬂow and venous outﬂow and map the greater
saphenous vein to evaluate its suitability as a conduit. We have
not measured ﬁstula ﬂow and have no experience with this ﬂow
algorithm. The etiology of early neurological deﬁcits is often difﬁ-
cult to discern. We base our treatment on the severity of symptoms
observed, rather than attempt to distinguish between types of
nerve injury. If a severe deﬁcit is observed we rapidly proceed to
DRIL or ﬁstula ligation. We have no experience with the banding
techniques described by Dr Berman, but ﬁnd them intriguing and
will follow his results with interest. Once again I thank Dr Berman
for his comments and the society for the privilege of the ﬂoor.
